89 related articles for article (PubMed ID: 12755063)
1. [Antiviral effect of sulfated sialyl lipid against a clinical strain of adenovirus].
Kaneko H; Mori S; Shigeta S; Ohno S; Aoki K
Nippon Ganka Gakkai Zasshi; 2003 Apr; 107(4):196-201. PubMed ID: 12755063
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
Kaneko H; Fujiwara T; Mori S; Shigeta S
Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):786-91. PubMed ID: 11530368
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of NMSO3 against adenovirus in vitro.
Kaneko H; Kato K; Mori S; Shigeta S
Antiviral Res; 2001 Dec; 52(3):281-8. PubMed ID: 11675145
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine on adenovirus].
Nakajima H; Goto M; Shimada Y; Nagamoto Y; Ishiko H; Inagawa W; Itoh N; Uchio E; Ohno S; Aoki K
Nippon Ganka Gakkai Zasshi; 2000 Feb; 104(2):77-81. PubMed ID: 10714154
[TBL] [Abstract][Full Text] [Related]
5. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.
Kodama E; Shigeta S; Suzuki T; De Clercq E
Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200
[TBL] [Abstract][Full Text] [Related]
6. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
Kaneko H; Mori S; Suzuki O; Iida T; Shigeta S; Abe M; Ohno S; Aoki K; Suzutani T
Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
8. Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives.
Romanutti C; Bruttomesso AC; Castilla V; Galagovsky LR; Wachsman MB
Chemotherapy; 2010; 56(2):158-65. PubMed ID: 20407244
[TBL] [Abstract][Full Text] [Related]
9. Anti-adenovirus activity, antioxidant potential, and phenolic content of black tea (Camellia sinensis Kuntze) extract.
Karimi A; Moradi MT; Alidadi S; Hashemi L
J Complement Integr Med; 2016 Dec; 13(4):357-363. PubMed ID: 27567600
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
Otová B; Votruba I; Holý A
Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759
[TBL] [Abstract][Full Text] [Related]
12. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of Plantago major extracts and related compounds in vitro.
Chiang LC; Chiang W; Chang MY; Ng LT; Lin CC
Antiviral Res; 2002 Jul; 55(1):53-62. PubMed ID: 12076751
[TBL] [Abstract][Full Text] [Related]
14. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.
Gordon YJ; Araullo-Cruz TP; Johnson YF; Romanowski EG; Kinchington PR
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro.
Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E
Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
Romanowski EG; Yates KA; Gordon YJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5295-9. PubMed ID: 19516011
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
18. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
20. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
